Drugs used to treat bipolar disorder act via microRNAs to regulate expression of genes involved in neurite outgrowth.

We conclude that at a transcriptional level, bipolar disorder drugs affect several genes in concert that would increase neurite outgrowth and neurogenesis and hence neural plasticity, and that this effect is mediated (at least in part) by modulation of the expression of these two key microRNAs.